Innovations and challenges in melanoma: summary statement from the first Cambridge conference

Michael B. Atkins*, David E. Elder, Richard Essner, Keith T. Flaherty, Thomas F. Gajewski, Frank G. Haluska, Patrick Hwu, Ulrich Keilholz, John M. Kirkwood, James W. Mier, Merrick I. Ross, Craig L. Slingluff, Vernon K. Sondak, Jeffrey A. Sosman, Martin A. Weinstock, Laura King

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Innovations and Challenges in Melanoma, chaired by Michael Atkins and cochaired by Ulrich Keilholz, John Kirkwood, and Jeffrey Sosman, was held July 15 to 16, 2005, in Cambridge, Massachusetts. The conference brought together leading experts in the fields of cancer research, medical oncology, surgical oncology, anatomic pathology, dermatology, and immunotherapy who wished to advance the field of melanoma treatment by exchanging information and perspectives regarding recent advances and recommendations for further study. The conference proceedings published in this educational supplement to Clinical Cancer Research are intended to provide timely information and recommendations on how genetics, biology, and data information can enhance our understanding of melanoma biology and help inform the use of therapies for this disease.

Original languageEnglish (US)
Pages (from-to)2291s-2296s
JournalClinical Cancer Research
Volume12
Issue number7 II
DOIs
StatePublished - Apr 1 2006

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Innovations and challenges in melanoma: summary statement from the first Cambridge conference'. Together they form a unique fingerprint.

Cite this